A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Formulation of sustained release dosage form of simvastatin and ezetimibe and analytical development by reversed phase high performance liquid chromatography (RP-HPLC)
Int. J. of Farmacia
unpublished
Preserved Fulltext
The present investigation relates to a process of preparing sustained release dosage forms containing simvastatin and ezetimibe in co mbination and assay by RP-HPLC method develop ment and validation. Chro matographic separation was achieved on a Water's Xterra colu mn (250 x 4.6, 5 microns) using a mobile phase consisting of Potassium di hydrogen phosphate and methanol in the rat io of 70:30 at a flo w rate of 0.8 ml per minute. The detection was made at 236 n m. The retention time of ezet
fatcat:hgiutvz4gjehzjijysmkiicuci